Dendritic cells are the professional antigen-presenting cells of the innate immune system
with the potential to generate robust antigen-specific T cell immune responses …

Importance of the field: Dendritic cells (DC) are powerful antigen-presenting cells that induce
and maintain primary cytotoxic T lymphocyte (CTL) responses directed against tumor …

Dendritic cells (DCs) play a crucial role in the induction of antigen-specific T-cell responses,
and therefore their use for the active immunotherapy of malignancies has been studied with …

Dendritic cells (DCs) have attracted considerable attention as potential targets for the
development of therapeutic cancer vaccines. This approach generally involves the …

Dendritic cell (DC)-based vaccination against cancer is a specific immunotherapy with a
new therapeutic approach for patients with cancer. Preclinical and clinical trials, in which …

Throughout the last decades, dendritic cell (DC)-based anti-tumor vaccines have proven to
be a safe therapeutic approach, although with inconsistent clinical results. The functional …

Recent advances in cancer immunotherapy have steadily increased the effectiveness of
standard antitumor therapy methods. Due to their low toxicity and simple production process …

The fifth international meeting on “Dendritic cell vaccination and other strategies to tip the
balance of the immune system” was held in Bamberg, Germany, on July 16–18, 2007. The 3 …

Dendritic cells (DC) are the most potent antigen presenting cells (APC) and the only ones
capable of presenting novel antigens to naïve T-cells. Large numbers of DC can be …

The unique ability of dendritic cells to pick up antigens and to activate naive and memory
CD4+ and CD8+ T cells raised the possibility of using them to trigger a specific anti-tumor …